ALIN - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 86148901
Serial Number
86148901
Registration Number
4824753
Word Mark
ALIN
Status
700 - Registered
Status Date
2015-10-06
Filing Date
2013-12-19
Registration Number
4824753
Registration Date
2015-10-06
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2015-07-21
Law Office Assigned Location Code
L40
Employee Name
HUDSON, TAMARA BREE
Statements
Goods and Services
Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, endocrinology for treatment of adrenal failure, thyroiditis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely rheumatology for treatment of rheumatoid arthritis, gout, post-traumatic arthritis, osteoarthritis, synovitis, bursitis, epicondylitis, ankylosing spondylitis, systemic or discoid lupus erythematosus, dermatomyositis, scleroderma, other collagen diseases, other osteoarticular diseases which require chronic corticosteroid administration; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory; immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely dermatology for treatment of pemphigus, erythema multiforme, exfoliative dermatitis, psoriasis, contact dermatitis, keloid lesions, hyperthrophic lichen planus, alopecia areata, urticaria, eczema, rosacea; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, allergology for treatment of bronchial asthma, urticaria, drug or food allergy, hypersensitivity reactions, allergic rhinitis, allergic sinusitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely otolaryngology for treatment of vasomotor rhinitis, other types of rhinitis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, ophthalmology for treatment of allergic, acute or chronic conjunctivitis; scleritis, uveitis/iridocyclitis, optic neuritis, corneal infections, keratitis, marginal ulcers, throphic disorders, conjunctival/corneal physical/chemical burning, inflammatory reactions; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, gastroenterology for treatment of ulcerative colitis, regional enteritis; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, pulmonology for treatment of bronchoaspiration, Löeffler syndrome, sarcoidosis, interstitial pulmonary fibrosis, chronic bronchitis, emphysema; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely hematology for treatment of autoimmune anemias or thrombocytopenias, leukemias, lymphomas, intravascular coagulation syndrome; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, oncology for treatment of nausea/vomiting associated with cancer chemotherapy prevention; Pharmaceutical preparations, namely, corticosteroid with anti-inflammatory, immunosuppressive and anti-allergic actions, alone or in combination with other active pharmaceutical principles, for use in different therapeutic areas, namely, miscellaneous for treatment of shock syndromes, cerebral edema
Translation of Words in Mark
The wording ALIN has no meaning in a foreign language.
Translation of Words in Mark
The English translation of the word "ALIN" in the mark is "LOWEST".
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2014-01-07
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
JENNIFER A. VAN KIRK
Address
Please log in with your Justia account to see this address.
Foreign Application Information
Filing DateApplication NumberCountryForeign Priority Claim In
MexicoFalse
Trademark Events
Event DateEvent Description
2013-12-23NEW APPLICATION ENTERED IN TRAM
2014-01-07NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-03-26ASSIGNED TO EXAMINER
2014-04-01NON-FINAL ACTION WRITTEN
2014-04-01NON-FINAL ACTION E-MAILED
2014-04-01NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-04-01NON-FINAL ACTION WRITTEN
2014-04-01NON-FINAL ACTION E-MAILED
2014-04-01NOTIFICATION OF NON-FINAL ACTION E-MAILED
2014-06-05TEAS RESPONSE TO OFFICE ACTION RECEIVED
2014-06-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2014-06-05TEAS/EMAIL CORRESPONDENCE ENTERED
2014-06-27ASSIGNED TO EXAMINER
2014-08-13EXAMINERS AMENDMENT -WRITTEN
2014-08-13EXAMINERS AMENDMENT E-MAILED
2014-08-13NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2014-08-13EXAMINER'S AMENDMENT ENTERED
2014-08-13APPROVED FOR PUB - PRINCIPAL REGISTER
2014-08-21ASSIGNED TO LIE
2014-08-22LAW OFFICE PUBLICATION REVIEW COMPLETED
2014-09-10NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2014-09-30PUBLISHED FOR OPPOSITION
2014-09-30OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2014-11-25NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2015-05-22TEAS PETITION TO AMEND BASIS RECEIVED
2015-05-22TEAS EXTENSION RECEIVED
2015-05-29ASSIGNED TO PETITION STAFF
2015-05-22EXTENSION 1 FILED
2015-06-01EXTENSION 1 GRANTED
2015-06-02NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2015-06-03PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
2015-06-03ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
2015-06-15NOTICE OF ALLOWANCE CANCELLED
2015-06-151(B) BASIS DELETED; NEW BASIS REQUESTED
2015-07-01NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-07-21PUBLISHED FOR OPPOSITION
2015-07-21OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2015-10-06REGISTERED-PRINCIPAL REGISTER
2020-10-06COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED